YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Allurion Technologies, Inc. (ALUR) one of those stocks right now? By taking a look at the stock's yea…
* Allurion Technologies (ALUR [https://seekingalpha.com/symbol/ALUR]) on Tuesday announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2.65M shares of c…
[Consumer Discretionary Apparel Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As earnings season ramps up and geopolitical tensions keep affecting the markets, below is a list of the c…
For Immediate Release Chicago, IL – November 18, 2025 – Today, Zacks Equity Research discusses Boston Scientific BSX, Insulet PODD, BioLife Solutions BLFS and Allurion Technologies ALUR. Industry: Medical Products Link: https://www.zacks.c…
The Zacks Medical - Products industry is grappling with a difficult operating landscape marked by tariff-driven cost inflation, persistent supply-chain delays, and uneven macroeconomic conditions that are pressuring margins and tempering n…
Earnings Call Insights: Allurion Technologies Inc. (ALUR) Q3 2025 MANAGEMENT VIEW * Shantanu Gaur, Co-Founder, CEO, President, Principal Financial & Accounting Officer and Director, highlighted recent progress with the FDA, remarking on se…
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan C…
Allurion Technologies, Inc. (ALUR) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurr…
Earnings Call Insights: Allurion Technologies Inc. (ALUR) Q2 2025 MANAGEMENT VIEW * Shantanu K. Gaur, CEO, stated that "our new strategy doubles down on metabolically healthy weight loss, losing weight, keeping it off and maintaining muscl…
NATICK, Mass. - Allurion Technologies, Inc. (NYSE:ALUR), currently trading at $2.88 with a market capitalization of $21.33 million, announced Wednesday a distribution partnership with Minogue Medical Inc. to bring its weight loss program t…
Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in France next month following the successful resumption of product shipments. This announcement comes on the heels o…
Insights into Yale University (Trades, Portfolio)'s Q3 2023 Investment Moves and Portfolio Adjustments Warning! GuruFocus has detected 2 Warning Sign with ACI. Yale University (Trades, Portfolio)'s Investment Office, renowned for its sophi…